Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Agnes Bombrun
Agnes Bombrun, Chambesy CH
| Patent application number | Description | Published |
|---|---|---|
| 20080207722 | Glepp-1 Inhibitors in the Treatment of Autoimmune and/or Inflammatory Disorders - The present invention is related to the use of a Glepp-1 inhibitor for the manufacture of a medicament for the treatment of an autoimmune and/or an inflammatory disorder. | 08-28-2008 |
| 20090018169 | Sulfonamide Derivatives for the Treatment of Bacterial Infections - This present invention is related to sulfonamide derivatives of Formula (I), pharmaceutical composition thereof, methods of preparation thereof and to their use for the treatment and/or prophylaxis of bacterial infections such as tuberculosis. | 01-15-2009 |
| 20090029903 | 1,1'-(1,2-Ethynediyl)Bis-Benzene Derivatives As Ptp 1-B Inhibitors - The present invention is related to carboxylic acids of Formula (I) and use thereof for the treatment and/or prevention of obesity and/or metabolic disorders mediated by insulin resistance or hyperglycemia, comprising diabetes type I and/or II, inadequate glucose tolerance, insulin resistance, hyperlipidemia, hypertriglyceridemia, hypercholesterolemia, polycystic ovary syndrome (PCOS). In particular, the present invention is related to the use of carboxylic acids of Formula (I) to modulate, notably to inhibit the activity of PTPs. | 01-29-2009 |
| 20090221575 | Sulfonamide derivatives and use thereof for the modulation of metalloproteinases - The present invention is related to sulfonamide derivatives of Formula (Ia) | 09-03-2009 |
| 20100210619 | 6-Amino-Pyrimidine-4-Carboxamide Derivatives and Related Compounds Which Bind to the Sphingosine 1-Phosphate (S1P) Receptor for the Treatment of Multiple Sclerosis - The invention relates to compounds of formula (I): | 08-19-2010 |
| 20100240658 | Oxadiazole Derivatives - The invention relates to compounds of formula I: | 09-23-2010 |
| 20100305104 | Oxadiazole Diaryl Compounds - The invention relates to compounds of formula (I): | 12-02-2010 |
Agnes Bombrun, Monnetier-Mornex FR
| Patent application number | Description | Published |
|---|---|---|
| 20100168101 | OXINDOLE HYDRAZIDE MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPS) - The present invention is related to the use of oxindole hydrazide derivatives of formula (I) for the treatment and/or prevention of metabolic disorders mediated by insulin resistance or hyperglycemia, comprising diabetes type I and/or II, inadequate glucose tolerance, insulin resistance, hyperlipidemia, hypertriglyceridemia, hypercholesterolemia, obesity, polycystic ovary syndrome (PCOS). In particular, the present invention is related to the use of oxindole hydrazide derivatives of formula (I) to modulate, notably to inhibit the activity of PTPs, in particular of PTP1B, TC-PTP, SHP and GLEPP-1. The present invention is furthermore related to novel oxindole hydrazide derivatives and method of preparation thereof. | 07-01-2010 |
| 20100280018 | Derivatives Of Hydroxamic Acid As Metalloproteinase Inhibitors - A compound of formula (I), or an enantiomer or diastereoisomer thereof, or a salt, hydrate or solvate thereof: | 11-04-2010 |